Medicus Pharma (NASDAQ:MDCX – Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.18) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.32) by $0.14, Zacks reports.
Medicus Pharma Stock Down 5.2 %
NASDAQ MDCX opened at $3.13 on Friday. Medicus Pharma has a twelve month low of $1.80 and a twelve month high of $6.00. The business’s 50-day simple moving average is $3.21.
Analyst Ratings Changes
A number of analysts have issued reports on MDCX shares. Maxim Group started coverage on shares of Medicus Pharma in a research note on Tuesday, December 17th. They issued a “buy” rating and a $10.00 target price for the company. Brookline Capital Management raised shares of Medicus Pharma to a “strong-buy” rating in a research note on Monday, December 23rd.
Medicus Pharma Company Profile
Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.
Further Reading
- Five stocks we like better than Medicus Pharma
- Quiet Period Expirations Explained
- MarketBeat Week in Review – 03/24 – 03/28
- Investing in Construction Stocks
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How to Short Nasdaq: An Easy-to-Follow Guide
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
